225 related articles for article (PubMed ID: 11356690)
1. Dihydrotestosterone enhances transforming growth factor-beta-induced apoptosis in hormone-sensitive prostate cancer cells.
Bruckheimer EM; Kyprianou N
Endocrinology; 2001 Jun; 142(6):2419-26. PubMed ID: 11356690
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 antagonizes the combined apoptotic effect of transforming growth factor-beta and dihydrotestosterone in prostate cancer cells.
Bruckheimer EM; Kyprianou N
Prostate; 2002 Oct; 53(2):133-42. PubMed ID: 12242728
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
4. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
Kim SG; Kim SN; Jong HS; Kim NK; Hong SH; Kim SJ; Bang YJ
Oncogene; 2001 Mar; 20(10):1254-65. PubMed ID: 11313870
[TBL] [Abstract][Full Text] [Related]
5. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
6. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
7. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
Kim IY; Zelner DJ; Lee C
Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
[TBL] [Abstract][Full Text] [Related]
8. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
10. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
[TBL] [Abstract][Full Text] [Related]
12. Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.
Song K; Wang H; Krebs TL; Kim SJ; Danielpour D
Cancer Res; 2008 Oct; 68(19):8173-82. PubMed ID: 18829577
[TBL] [Abstract][Full Text] [Related]
13. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta induces cell death in the oligodendroglial cell line OLI-neu.
Schuster N; Bender H; Philippi A; Subramaniam S; Strelau J; Wang Z; Krieglstein K
Glia; 2002 Oct; 40(1):95-108. PubMed ID: 12237847
[TBL] [Abstract][Full Text] [Related]
15. Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kip1 and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells.
Ye D; Mendelsohn J; Fan Z
Clin Cancer Res; 1999 Aug; 5(8):2171-7. PubMed ID: 10473102
[TBL] [Abstract][Full Text] [Related]
16. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors.
Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H
J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308
[TBL] [Abstract][Full Text] [Related]
17. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
Cipriano SC; Chen YQ
Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
[TBL] [Abstract][Full Text] [Related]
18. Role of CD14 expression in the differentiation-apoptosis switch in human monocytic leukemia cells treated with 1alpha,25-dihydroxyvitamin D3 or dexamethasone in the presence of transforming growth factor beta1.
Kanatani Y; Kasukabe T; Okabe-Kado J; Yamamoto-Yamaguchi Y; Nagata N; Motoyoshi K; Honma Y
Cell Growth Differ; 1999 Oct; 10(10):705-12. PubMed ID: 10547074
[TBL] [Abstract][Full Text] [Related]
19. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation.
Saltzman A; Munro R; Searfoss G; Franks C; Jaye M; Ivashchenko Y
Exp Cell Res; 1998 Jul; 242(1):244-54. PubMed ID: 9665822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
